Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;39(9):e807-e811.
doi: 10.1111/jdv.20699. Epub 2025 Apr 17.

Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study

Affiliations

Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study

Luigi Gargiulo et al. J Eur Acad Dermatol Venereol. 2025 Sep.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Boesjes CM, Kamphuis E, de Graaf M, Spekhorst LS, Haeck I, van der Gang LF, et al. Long‐term effectiveness and reasons for discontinuation of Dupilumab in patients with atopic dermatitis. JAMA Dermatol. 2024;160(10):1044–1055. https://doi.org/10.1001/jamadermatol.2024.2517
    1. Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema: part I‐systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409–1431. https://doi.org/10.1111/jdv.18345
    1. Gargiulo L, Ibba L, Malagoli P, Burroni AG, Chiricozzi A, Dapavo P, et al. Management of patients affected by moderate‐to‐severe atopic dermatitis with JAK inhibitors in real‐world clinical practice: an Italian Delphi consensus. Dermatol Ther. 2024;14(4):919–932. https://doi.org/10.1007/s13555‐024‐01135‐x
    1. European Medicines Agency. Dupixent (dupilumab): summary of product characteristics; 2017. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/dupixent. [Accessed 29 October 2024]
    1. Agenzia Italiana del Farmaco (AIFA). Dupixent (dupilumab). Available from: https://www.aifa.gov.it/documents/20142/961234/Determina_646‐2024_Dupilu... [Accessed 2025 January 28]

LinkOut - more resources